Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Bock

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Cardiovascular Pharmacology|January 1, 1995
ET-1 excretion is urine flow-dependent in kidney donors and transplant recipientsM Zeiler, B M Löffler, H A Bock, et al.
Nephron|January 1, 1991
Failure of verapamil to protect from ischaemic renal damageH A Bock, F P Brunner, J Torhorst, et al.
Transplantation|May 27, 1994
Weight-independent dosing of cyclosporine--an alternative to the "mg/kg" doctrineH A Bock, V Kamber, F P Brunner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986
Effects of intravenous aspirin on prostaglandin synthesis and kidney function in intensive care patientsH A Bock, J C Frölich, R Ritz, et al.
The American Journal of Physiology|May 1, 1990
Measurement of renin secretion in single perfused rabbit glomeruliH A Bock, M Hermle, A Fiallo, et al.
Schweizerische Medizinische Wochenschrift|December 7, 1991
[Glomerular hyperfiltration following unilateral nephrectomy in healthy subjects]H A Bock, M Gregor, B Huser, et al.
Kidney International|December 1, 1989
Long-term enalapril and verapamil in rats with reduced renal massF P Brunner, G Thiel, M Hermle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Control of hypertension by verapamil enhances renal damage in a rat remnant kidney modelF P Brunner, H A Bock, M Hermle, et al.
Transplantation|March 27, 1995
A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantationH A Bock, H Gallati, R M Zürcher, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Cardiovascular Pharmacology|January 1, 1995
ET-1 excretion is urine flow-dependent in kidney donors and transplant recipientsM Zeiler, B M Löffler, H A Bock, et al.
Nephron|January 1, 1991
Failure of verapamil to protect from ischaemic renal damageH A Bock, F P Brunner, J Torhorst, et al.
Transplantation|May 27, 1994
Weight-independent dosing of cyclosporine--an alternative to the "mg/kg" doctrineH A Bock, V Kamber, F P Brunner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986
Effects of intravenous aspirin on prostaglandin synthesis and kidney function in intensive care patientsH A Bock, J C Frölich, R Ritz, et al.
The American Journal of Physiology|May 1, 1990
Measurement of renin secretion in single perfused rabbit glomeruliH A Bock, M Hermle, A Fiallo, et al.
Schweizerische Medizinische Wochenschrift|December 7, 1991
[Glomerular hyperfiltration following unilateral nephrectomy in healthy subjects]H A Bock, M Gregor, B Huser, et al.
Kidney International|December 1, 1989
Long-term enalapril and verapamil in rats with reduced renal massF P Brunner, G Thiel, M Hermle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1991
Control of hypertension by verapamil enhances renal damage in a rat remnant kidney modelF P Brunner, H A Bock, M Hermle, et al.
Transplantation|March 27, 1995
A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantationH A Bock, H Gallati, R M Zürcher, et al.
Pageof 2